Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis (IPHC)

Clinical Trial ID NCT00454519

Rank	Title	Journal	Year	PubWeight™‹?›
1	Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.	Ann Surg Oncol	2011	4.16
2	Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.	Ann Surg Oncol	2008	0.97
3	Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center.	PLoS One	2014	0.83
4	Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in Mainland China.	World J Gastroenterol	2011	0.79
5	Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.	World J Surg Oncol	2016	0.75